Dr. Joseph Geraci has been working on a precision medicine paradigm for 8 years and NetraAI is the result of this effort. He has a doctorate in mathematical physics and completed post doctoral positions in oncology and psychiatry, in addition to an industrial post doc in machine learning. He is currently the CEO of NetraMark Corp and has created NetraAI - an innovative machine learning system that is being used to extract novel insights about Parkinson's disease, certain cancers, Alzheimer's, bipolar disorder, schizophrenia, and depression. A major innovation provided by NetraAI is the ability to interact with high dimensional models from different perspectives so that human experts can make and test hypotheses through a quick and simple process. A user can "ask" the system to explain which variables are driving the separation of clusters of patients. Thus, in addition to utilizing many machine learning algorithms, the system augments human expertise, and through this concerted effort, reliable models emerge.